Join/Renew Now

Zero Tolerance Anti-Doping Newsletter
Volume 3, Issue 6 - November 2006

In This Issue

Why Zero Tolerance?

USA Track & Field CEO Craig A. Masback and USATF President Bill Roe developed the plan in concert with the USATF Board of Directors in October 2003 by combining existing programs and USATF priorities with ambitious new initiatives. "Zero Tolerance" focuses on three goals: increasing efforts to catch and punish cheaters; expanding educational efforts and focusing the message on the theme that cheating is wrong and cheaters will be caught; and taking a more visible role on these issues.


Changes to the WADA Prohibited List - Effective January 1, 2007

The World Anti-Doping Agency (WADA) has published the 2007 Prohibited List. Below is a summary of updates from the 2006 List to the 2007 List. For a full copy of the 2007 Prohibited List, visit WADA's website. The 2007 Prohibited List will go into effect January 1, 2007.

The Classes of Prohibited Substances have not changed from the 2006 List.

However , in order to make the language clearer, the explanatory paragraphs for the following four classes of substances in the 2007 List have been reworded:

  • Anabolic Agents
  • Diuretics
  • Chemical and physical manipulation
  • Stimulants

Other Updates to the 2007 List:

Beta-2 agonists
Salbutamol used by inhalation, even with an Abbreviated Therapeutic Use Exemption (ATUE), is not a specified substance** at urinary levels greater than 1000 ng/ml.

Glucocorticosteroids
Glucocorticosteroids used by iontophoresis/phonophoresis are permitted and do not require an Abbreviated TUE. Other topical treatments such as skin, eye, ear, nose, and inside the mouth are also permitted.

Glucocorticosteroids are only permitted in competition. Other routes of administration (intraarticular, periarticular, peritendinous, epidural, intradermal injections and inhalation) require an Abbreviated TUE for use in competition. Systematic use of corticosteroids by oral, intravenous, intramuscular, or rectal use requires an approved standard TUE before use in competition.

Stimulants
Imidazole derivatives used as topical preparations are permitted.

**Specified substances are those substances that are particularly susceptible to unintentional anti-doping rule violations due their general availability in medicinal products and because they are less likely to be successfully abused as doping agents.

Altitude Tents Not Added to 2007 Prohibited List

After a thorough scientific and ethical review by WADA's scientific committees, WADA's Executive Committee approved the recommendation to NOT add artificially-induced hypoxic conditions (i.e. altitude tens, hypoxic chambers) to the 2007 Prohibited List.

Committee members suggested that the International Olympic Committee (IOC) Medical Commission look into the matter for a medical consideration of the method's impact on athlete health.


Latest News

IAAF Anti-Doping Symposium Recap

The 2006 IAAF World Anti-Doping Symposium in Lausanne, like those held in Florence in 1987 and in Monte Carlo in 1989, was born of the IAAF's determination to remain at the forefront of the fight against doping, a fight we are determined to pursue relentlessly. The 3rd IAAF World Anti-Doping Symposium took place in Lausanne, Switzerland, from September 30 until October 2, 2006 before an audience of nearly 400 participants from all around the world, composed of representatives of IAAF federations, but also WADA, the IOC and other sports organizations, laboratories, other anti-doping professionals and representatives of the Media, who had full access to all the sessions.

IAAF President Lamine Diack opened the symposium, citing that the new directions the IAAF is embarking upon were mainly born of two major occurrences. The first one was the adoption of the World Anti-Doping Code in 2003, followed by, in the same year, the infamous "BALCO affair."

Among the key messages was maintaining transparency in the IAAF Anti-Doping program and the importance of IAAF testing systems that continues to concentrate more on the quality testing rather than quantity, the so-called "intelligent testing". It was also clear that International cooperation between anti-doping stakeholders is vital and must occur for the doping fight to be effective. There were also a number of recommendations for the future direction of the program including further discussion of the "no start rule" concerning pre-competition blood testing and eventually moving towards prosecuting doping cases on the basis of individual steroid and blood profiles rather than the reliance on thresholds set by the public norm. Throughout the Symposium, one constant theme was that athletes must be fully involved and consulted in any discussions on anti-doping issues.

The most recent IAAF statistics available show that, in 2005, 20,000 athletes were tested both in- and out-of-competition and that over 1300 blood samples from international-level athletes alone were analyzed. Over the past three years, the IAAF has increased the budget it dedicates to testing by 60%, and it now amounts, for 2006, to 2,600,000 USD. The importance of the measures taken to fight against doping can also be gauged by a recruitment drive in the IAAF Medical and Anti-Doping department, which has grown from five to eleven employees.

Athletes' Voice

Former Olympic Triple Champion, USATF Executive Director of Elite Athlete Services Michael Conley highlighted that athletes must be viewed as equal partners in the fight against doping and continued discussion should be maintained between the athletes and the anti-doping administrators. He highlighted that athletes are committed to the anti-doping process but work must continue on simplifying the process for the athletes. Paula Radcliffe, current World record holder in the women's Marathon, also spoke with passion about the continued need to progress in the anti-doping work of the IAAF. Radcliffe highlighted the need for continued refinement of the testing procedures, and the need for standards of anti-doping work to be maintained in all countries not just some.

Modern methods for prevention and deterrence of doping

A large proportion of the first two days discussion were of a scientific nature and concentrated on techniques for the detection of doping, so day three provided a change of pace as participants came together to discuss the more administrative methods for prevention and deterrence. Stephane Diagana, former World Champion at 400m Hurdles and now a member of IAAF and WADA Athlete Commissions, provided an alternative option for the deterrence of doping. He re-affirmed the athletes' 100% commitment to drug-free sport and proposed financial penalties as part of the sanctioning process. The final athlete to speak was Debbie Ferguson, a medalist at the last three Olympic Games. She spoke with a composure and passion that left all participants in the auditorium in no doubt of the commitment that the majority of athletes have to compete drug free. She also highlighted the difficulties of trying to comply with strict IAAF athlete whereabouts but provided suggestions for improvements.

Prof Arne Ljungqvist, IAAF Senior Vice President, closed the Symposium and asked all delegates to reflect on the lessons they had learned at the Symposium and find ways to apply them in their own anti-doping work.

USADA Announces 3rd Quarter Testing Numbers

USADA announced their testing numbers for the 3rd quarter of 2006 - performing a total of 2,156 doping control testing in 69 Olympic, Paralympic and Pan American sports, including 2,069 domestic tests. Out-of-Competition (OOC) testing comprised approximately 55 percent (1,130) of the domestic tests USADA conducted in the third quarter of 2006. For track and field, 1,419 tests have been conducted in 2006, including 263 overall tests in the third quarter.

Athletes Hit with Suspensions for 3 Missed Tests

Two athletes were recently charged with doping violations for failure to comply with their National Anti-Doping Agency Out-of-Competition (OOC) Testing protocols and accruing three missed tests within an 18-month period.

The British Triathlon Association announced that World Triathlon champion Tim Don would receive a three-month suspension after missing three out-of-competition drug tests. Despite being tested with no adverse findings for drugs on nine separate occasions in 2006, Don decided not to appeal the punishment. The anti-doping violation was attributed "to a combination of forgetfulness on the athlete's behalf and his lack of understanding of the new testing system," according to the BTA and an independent disciplinary tribunal.

USADA announced that cyclist James Mortenson would receive a two-year suspension for missing three out-of-competition drug tests. Mortenson accrued his missed tests by both failing to submit his quarterly whereabouts information and for being unavailable for an OOC testing attempt in October 2005, despite his knowledge that he was in violation of the testing rules. All competitive results achieved by Mortenson subsequent to the October missed tests, the date of the last missed tests, were disqualified.

"'This is a tough reminder to all athletes that they must make themselves available for testing or suffer the consequences," said USADA CEO Terry Madden.

USADA Reminder

Athlete Location Forms are due to USADA on December 1 for the 1st Quarter of 2007. If you have a question about your status in the USADA OOC Pool, please contact USATF's Melissa Beasley at 317-713-4650.

Athletes can submit forms electronically or via fax (719-785-2099). Forms can also be mailed to USADA at 1330 Quail Lake Loop, Suite 260, Colorado Springs, CO 80906.

USATF recommends that athletes always keep a copy of their quarterly athlete location form after they have submitted it to USADA for their personal records.


Things to Consider

From the USADA Spirit of Sport Newsletter:

Feeling a cold coming on???

As the seasons change, the number of athletes suffering from colds, allergies, sinus infections and headaches increases. Before you rush to the store to buy medicines for your symptoms, be sure to check USADA's Drug Reference resources to ensure the medication is permitted.

Don't let an avoidable mistake ruin your career. USADA's Drug Reference resources are in place to help protect you.

  1. Drug Reference Line: 800-233-0393 (inside USA) or 719-785-2020 (outside the USA)
  2. USADA's Guide and Wallet Card are available on USADA's home page at www.usantidoping.org
  3. Drug Reference Online: www.usantidoping.org/dro

Upcoming Events

Nov. 29 - Dec. 3 USATF Annual Meeting, Indianapolis, IN
Jan. 14 USA Half Marathon Championships, Houston, TX
Jan. 28 USA 50 km Race Walk Championships, Chula Vista, CA
Feb. 10 USA Cross Country Championships, Boulder, CO
Feb. 23-25 USA Indoor Track & Field Championships, Boston, MA
Mar. 3-4 USA Indoor Combined Events Championships, Chapel Hill, NC

Forms


Important Numbers

  • USADA Drug Reference Line - 800-233-0393 (toll free)
  • USATF Whistleblower Hotline - 866-809-8104 (toll free) - Athletes, coaches, and the public can contact this number to report information in confidence.
  • USADA Whistleblower Hotline - 877-PLAY CLEAN (toll free)
  • USATF Anti-Doping Liaison (Melissa Beasley) - 317-713-4650

Links to other Anti-Doping Websites

Nike Visa BMW Gatorade Gill Athletics St. Vincent Lynx